Michael Kauffman, Director at Karyopharm Therapeutics, holds 1.61M shares in Karyopharm Therapeutics (Ticker: KPTI), holds ― shares in Infinity Pharmaceuticals (Ticker: INFIQ), holds 5.90K shares in Adicet Bio (Ticker: ACET). Most recently, Michael Kauffman Sold ― shares of Karyopharm Therapeutics on Mar 02, 2022 for an estimated value of 127.38K.